These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11389114)

  • 1. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus.
    Rossi L; Serafini S; Cappellacci L; Balestra E; Brandi G; Schiavano GF; Franchetti P; Grifantini M; Perno CF; Magnani M
    J Antimicrob Chemother; 2001 Jun; 47(6):819-27. PubMed ID: 11389114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency metabolism and activity against human immunodeficiency virus or herpes simplex virus.
    Perno CF; Santoro N; Balestra E; Aquaro S; Cenci A; Lazzarino G; Di Pierro D; Tavazzi B; Balzarini J; Garaci E; Grimaldi S; Caliò R
    Antiviral Res; 1997 Feb; 33(3):153-64. PubMed ID: 9037372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.
    Perno CF; Balestra E; Aquaro S; Panti S; Cenci A; Lazzarino G; Tavazzi B; Di Pierro D; Balzarini J; Calio R
    Mol Pharmacol; 1996 Aug; 50(2):359-66. PubMed ID: 8700144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir.
    Rossi L; Brandi G; Schiavano GF; Balestra E; Millo E; Scarfi S; Damonte G; Gasparini A; Magnani M; Perno CF; Benatti U; De Flora A
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):435-44. PubMed ID: 9546803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Rossi L; Dominici S; Serafini S; Casabianca A; Cerasi A; Chiarantini L; Celeste AG; Cappellacci L; Franchetti P; Grifantini M; Magnani M
    J Antimicrob Chemother; 2002 Sep; 50(3):365-74. PubMed ID: 12205061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Naesens L; Balzarini J; Bischofberger N; De Clercq E
    Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability.
    Benzaria S; Pélicano H; Johnson R; Maury G; Imbach JL; Aubertin AM; Obert G; Gosselin G
    J Med Chem; 1996 Dec; 39(25):4958-65. PubMed ID: 8960556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus.
    Franchetti P; Abu Sheikha G; Cappellacci L; Marchetti S; Grifantini M; Balestra E; Perno C; Benatti U; Brandi G; Rossi L; Magnani M
    Antiviral Res; 2000 Sep; 47(3):149-58. PubMed ID: 10974367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine.
    Starrett JE; Tortolani DR; Hitchcock MJ; Martin JC; Mansuri MM
    Antiviral Res; 1992 Sep; 19(3):267-73. PubMed ID: 1332606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phosphonylmethoxyethyl)adenine.
    Foster SA; Cerny J; Cheng YC
    J Biol Chem; 1991 Jan; 266(1):238-44. PubMed ID: 1845964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
    Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel hepatotrophic prodrugs of the antiviral nucleoside 9-(2-phosphonylmethoxyethyl)adenine with improved pharmacokinetics and antiviral activity.
    Biessen EA; Valentijn AR; De Vrueh RL; Van De Bilt E; Sliedregt LA; Prince P; Bijsterbosch MK; Van Boom JH; Van Der Marel GA; Abrahams PJ; Van Berkel TJ
    FASEB J; 2000 Sep; 14(12):1784-92. PubMed ID: 10973928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
    Magnani M; Casabianca A; Fraternale A; Brandi G; Gessani S; Williams R; Giovine M; Damonte G; De Flora A; Benatti U
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4403-8. PubMed ID: 8633079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
    Starrett JE; Tortolani DR; Russell J; Hitchcock MJ; Whiterock V; Martin JC; Mansuri MM
    J Med Chem; 1994 Jun; 37(12):1857-64. PubMed ID: 8021925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-protecting effect against herpes simplex virus-1 and cellular metabolism of 9-(2-phosphonylmethoxyethyl)adenine in HeLa S3 cells.
    Cerny J; Foster SA; Cheng YC
    Mol Pharmacol; 1992 Sep; 42(3):537-44. PubMed ID: 1328849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug targeting: anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine.
    Midoux P; Negre E; Roche AC; Mayer R; Monsigny M; Balzarini J; De Clercq E; Mayer E; Ghaffar A; Gangemi JD
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1044-9. PubMed ID: 2157421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections.
    Gangemi JD; Cozens RM; De Clercq E; Balzarini J; Hochkeppel HK
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1864-8. PubMed ID: 2482011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier-mediated delivery improves the efficacy of 9-(2-phosphonylmethoxyethyl)adenine against hepatitis B virus.
    Bijsterbosch MK; Ying C; de Vrueh RL; de Clercq E; Biessen EA; Neyts J; van Berkel TJ
    Mol Pharmacol; 2001 Sep; 60(3):521-7. PubMed ID: 11502883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a lipophilic prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and its incorporation into a hepatocyte-specific lipidic carrier.
    de Vrueh RL; Rump ET; Sliedregt LA; Biessen EA; van Berkel TJ; Bijsterbosch MK
    Pharm Res; 1999 Aug; 16(8):1179-85. PubMed ID: 10468017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.